Download full-text PDF

Source
http://dx.doi.org/10.1227/neu.0000000000002067DOI Listing

Publication Analysis

Top Keywords

commentary risk
4
risk factors
4
factors neurological
4
neurological outcomes
4
outcomes associated
4
associated circulatory
4
circulatory shock
4
shock moderate-severe
4
moderate-severe traumatic
4
traumatic brain
4

Similar Publications

Response to: 'Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank' by Møller .

J Med Genet

January 2025

Department of Gastroenterology, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

View Article and Find Full Text PDF

Seizures in people with Alzheimer's disease are increasingly recognized to worsen disease burden and accelerate functional decline. Harnessing established antiseizure medicine discovery strategies in rodents with Alzheimer's disease associated risk genes represents a novel way to uncover disease modifying treatments that may benefit these Alzheimer's disease patients. This commentary discusses the recent evaluation by Dejakaisaya and colleagues to assess the antiseizure and disease-modifying potential of the repurposed cephalosporin antibiotic, ceftriaxone, in the Tg2576 mouse model.

View Article and Find Full Text PDF

The Latarjet procedure is a successful treatment for anterior shoulder instability with less than 5% having redislocations - revision surgery and prior surgery having been shown to be significant risk factors for recurrence. Approximately 90% of athletes return to play after Latarjet, comparable to arthroscopic Bankart repair. Patients may be physically unable to return to play, which may be due to persistent pain, apprehension, or weakness.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!